No Data
No Data
RON97 Petrol Price Up By 3 Sen; RON95 And Diesel Unchanged
BESS Programme: A Game Changer for the Malaysian Energy Landscape?
ASEAN Power Sector Aims To Achieve 50% RE Capacity By 2040
Express News | Ocugen Announced That The Data And Safety Monitoring Board For OCU410 ArMaDa Clinical Trial Recently Convened And Approved The Continuation Of The Second Phase Of The Phase 1/2 Study
Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Malaysia Closing Bell on Dec 17 | TENAGA Was the Top Gainer of FBM KLCI